| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |